ATE498398T1 - Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus - Google Patents
Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virusInfo
- Publication number
- ATE498398T1 ATE498398T1 AT04782095T AT04782095T ATE498398T1 AT E498398 T1 ATE498398 T1 AT E498398T1 AT 04782095 T AT04782095 T AT 04782095T AT 04782095 T AT04782095 T AT 04782095T AT E498398 T1 ATE498398 T1 AT E498398T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- virus
- treatment
- heterocycles
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50206703P | 2003-09-11 | 2003-09-11 | |
PCT/US2004/027533 WO2005034850A2 (en) | 2003-09-11 | 2004-08-24 | Cycloalkyl heterocycles for treating hepatitis c virus |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE498398T1 true ATE498398T1 (de) | 2011-03-15 |
Family
ID=34434839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04782095T ATE498398T1 (de) | 2003-09-11 | 2004-08-24 | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus |
Country Status (7)
Country | Link |
---|---|
US (1) | US7112601B2 (de) |
EP (1) | EP1663105B1 (de) |
JP (1) | JP4897484B2 (de) |
AT (1) | ATE498398T1 (de) |
DE (1) | DE602004031435D1 (de) |
ES (1) | ES2358904T3 (de) |
WO (1) | WO2005034850A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT502258B1 (de) * | 2005-07-22 | 2007-09-15 | Univ Wien | Cox-i-inhibitorverbindungen |
WO2007019397A2 (en) * | 2005-08-05 | 2007-02-15 | Genelabs Technologies, Inc. | 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
BRPI0716060A2 (pt) * | 2006-08-17 | 2013-09-17 | Boehringer Ingelheim Int | inibidores de polimerase viral. |
WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
JP2010520200A (ja) * | 2007-02-28 | 2010-06-10 | クオナトウス ファーマシューティカルズ,インコーポレイテッド | 特定のマトリックスメタロプロテイナーゼ(mmp)阻害剤を使用する肝疾患を治療する方法 |
JP2010526143A (ja) | 2007-05-04 | 2010-07-29 | バーテックス ファーマシューティカルズ インコーポレイテッド | Hcv感染の処置のための併用療法 |
WO2009028418A1 (ja) | 2007-08-24 | 2009-03-05 | Sapporo Medical University | シクロスポリンa結合タンパク質 |
EA201000948A1 (ru) | 2007-12-19 | 2011-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Ингибиторы вирусной полимеразы |
UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
CN102271699A (zh) | 2009-01-07 | 2011-12-07 | 西尼克斯公司 | 用于治疗hcv和hiv感染的环孢菌素衍生物 |
MX2013007677A (es) | 2010-12-30 | 2013-07-30 | Abbvie Inc | Inhibidores macrociclicos de serina proteasa de hepatitis. |
PE20140039A1 (es) | 2010-12-30 | 2014-03-01 | Enanta Pharm Inc | Inhibidores de serina proteasa de hepatitis c a base de macrociclicos de fenantridina |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
EP3759095A1 (de) | 2018-03-01 | 2021-01-06 | Annapurna Bio Inc. | Verbindungen und zusammensetzungen zur behandlung von erkrankungen in zusammenhang mit der apj-rezeptoraktivität |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997014679A2 (en) * | 1995-10-17 | 1997-04-24 | G.D. Searle & Co. | Method of detecting cyclooxygenase-2 |
US6492423B1 (en) | 1998-07-27 | 2002-12-10 | Istituto Di Ricerche Di Biologia Molecolare Pangeletti Spa | Diketoacid-derivatives as inhibitors of polymerases |
IL141456A0 (en) | 1998-08-21 | 2002-03-10 | Viropharma Inc | Rhodanine derivatives and pharmaceutical compositions containing the same |
WO2000013708A1 (en) | 1998-09-04 | 2000-03-16 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
EP1115286A4 (de) | 1998-09-25 | 2003-07-23 | Viropharma Inc | Verfahren zur behandlung und vorbeugung viraler infektionen und damit verbundener erkrankungen |
AU1324300A (en) * | 1998-10-26 | 2000-05-15 | Vertex Pharmaceuticals Incorporated | Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase |
WO2001032153A2 (en) | 1999-11-04 | 2001-05-10 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
CA2363274A1 (en) | 1999-12-27 | 2001-07-05 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs for hepatitis c |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP1256628A3 (de) | 2001-05-10 | 2003-03-19 | Agouron Pharmaceuticals, Inc. | Hepatitis C Virus (HCV) NS5B RNA Polymerase und davon abgeleitete Mutanten |
AP1753A (en) | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
WO2003007945A1 (en) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP2335700A1 (de) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
US20030134853A1 (en) | 2001-09-26 | 2003-07-17 | Priestley Eldon Scott | Compounds useful for treating hepatitis C virus |
-
2004
- 2004-08-19 US US10/922,096 patent/US7112601B2/en not_active Expired - Lifetime
- 2004-08-24 ES ES04782095T patent/ES2358904T3/es not_active Expired - Lifetime
- 2004-08-24 WO PCT/US2004/027533 patent/WO2005034850A2/en active Application Filing
- 2004-08-24 EP EP04782095A patent/EP1663105B1/de not_active Expired - Lifetime
- 2004-08-24 DE DE602004031435T patent/DE602004031435D1/de not_active Expired - Lifetime
- 2004-08-24 AT AT04782095T patent/ATE498398T1/de not_active IP Right Cessation
- 2004-08-24 JP JP2006526121A patent/JP4897484B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4897484B2 (ja) | 2012-03-14 |
WO2005034850A2 (en) | 2005-04-21 |
ES2358904T3 (es) | 2011-05-16 |
EP1663105A4 (de) | 2009-04-15 |
US20050075376A1 (en) | 2005-04-07 |
WO2005034850A3 (en) | 2006-03-16 |
EP1663105B1 (de) | 2011-02-16 |
EP1663105A2 (de) | 2006-06-07 |
US7112601B2 (en) | 2006-09-26 |
JP2007505114A (ja) | 2007-03-08 |
DE602004031435D1 (de) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700338A1 (ru) | Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с и композиции и способы лечения с их использованием | |
ATE432922T1 (de) | Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide | |
PL1987038T3 (pl) | Inhibitory HCV NS5B | |
DE602008004317D1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
EA200802346A1 (ru) | Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с | |
CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
TW200518746A (en) | Novel inhibitors of hepatitis C virus NS3/NS4A serine protease | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
WO2004002940A8 (en) | Inhibitors of hcv ns5b polymerase | |
EA200800371A1 (ru) | Ингибиторы ns3 протеазы вгс | |
WO2006012078A3 (en) | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
EA201001273A1 (ru) | Ингибиторы вируса гепатита с | |
JO2318B1 (en) | Nucleoside derivatives used as DNA-based viral RNA inhibitors | |
ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
MX2012008443A (es) | Nucleosidos antiviricos. | |
DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
ATE491706T1 (de) | Heterocyclische antivirale verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |